Utility of non-high-density lipoprotein cholesterol in assessing incident type 2 diabetes risk

Diabetes, Obesity and Metabolism

Volumn 14, Issue 9, 2012, Pages 821-825

  Ley, S H ^a   Harris, S B ^b   Connelly, P W ^c,d   Mamakeesick, M ^e   Gittelsohn, J ^f   Wolever, T M ^a   Hegele, R A ^g   Zinman, B ^a,h   Hanley, A J ^a,h  

^a UNIVERSITY OF TORONTO   (Canada)

^b WESTERN UNIVERSITY   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e Sandy Lake Health and Diabetes Project   (Canada)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^g ROBARTS RESEARCH INSTITUTE   (Canada)

^h MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Dyslipidemia; Lipids; Lipoproteins; Non HDL cholesterol; Type 2 diabetes

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NON HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ABORIGINE; ADULT; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; CLINICAL ASSESSMENT; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIET RESTRICTION; DYSLIPIDEMIA; FEMALE; HUMAN; INCIDENCE; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PARAMETRIC TEST; RISK; TREATMENT OUTCOME; UNIVARIATE ANALYSIS; WAIST CIRCUMFERENCE;

EID: 84864326496     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2012.01607.x     Document Type: Article

References (19)

1. Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy Lancet 2005; 365: 1333-1346.
2. Knowler WC, Barrett-Connor E, Fowler SE et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N Engl J Med 2002; 346: 393-403.
3. Tuomilehto J, Lindstrom J, Eriksson JG et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance N Engl J Med 2001; 344: 1343-1350.
4. Wilson PWF, Meigs JB, Sullivan L, Fox CS, Nathan DM, D'Agostino RB Sr. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham offspring study Arch Intern Med 2007; 167: 1068-1074.
5. Genest J, McPherson R, Frohlich J et al. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations Can J Cardiol 2009 25: 567-579.
6. National Cholesterol Education Program. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 2001; 285: 2486-2497.
7. Shai I, Rimm EB, Hankinson SE et al. Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines Circulation 2004; 110: 2824-2830.
8. Jiang R, Schulze MB, Li T et al. Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes Diabetes Care 2004; 27: 1991-1997.
9. Ridker PM, Rifai N, Cook NR, Bradwin G, Buring JE. Non-HDL cholesterol, apolipoproteins A-1 and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women JAMA 2005; 294: 326-333.
10. El Harchaoui K, van der Steeg WA, Stroes ESG et al. Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study J Am Coll Cardiol 2007; 49: 547-553.
11. Ley SH, Harris SB, Mamakeesick M et al. Metabolic syndrome and its components as predictors of incident type 2 diabetes mellitus in an Aboriginal community CMAJ 2009; 180: 617-624.
12. Hadaegh F, Hatami M, Tohidi M, Sarbakhsh P, Saadat N, Azizi F. Lipid ratios and appropriate cut off values for prediction of diabetes: a cohort of Iranian men and women Lipids Health Dis 2010; 9: 85.
13. Harris S, Gittelsohn J, Hanley A et al. The prevalence of NIDDM and associated risk factors in Native Canadians Diabetes Care 1997; 20: 185-187.
14. Harris SB, Zinman B, Hanley A et al. The impact of diabetes on cardiovascular risk factors and outcomes in a native Canadian population Diabetes Res Clin Pract 2002; 55: 165-173.
15. Lipid Research Clinics Program. Manual of Laboratory Operations Washington, DC: Govt. Printing Office (NIH publ. no. 75-6282), 1984; 1-81.
16. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach Biometrics 1988; 44: 837-845.
17. Sniderman A, McQueen M, Contois J, Williams K, Furberg CD. Why is non-high-density lipoprotein cholesterol a better marker of the risk of vascular disease than low-density lipoprotein cholesterol? J Clin Lipidol 2010; 4: 152-155.
18. Jensen MD, Haymond MW, Rizza RA, Cryer PE, Miles JM. Influence of body fat distribution on free fatty acid metabolism in obesity J Clin Invest 1989; 83: 1168-1173.
19. Ferrannini E, Barrett EJ, Bevilacqua S, DeFronzo RA. Effect of fatty acids on glucose production and utilization in man J Clin Invest 1983; 72: 1737-1747.